Anti-Human IL-2R alpha (CD25) (Basiliximab) PE
Product Sizes
50 µg
£628.00
12-8082-50UG
About this Product
- SKU:
- 12-8082
- Additional Names:
- IL-2-RA; IL2-RA; TAC antigen; p55; CD25
- translate.label.attr.clone:
- Hu107
- Clonality:
- Monoclonal
- Extra Details:
- Expression Host : HEK-293 This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Basiliximab. Basiliximab recognizes human CD25. This product is for research use only. CD25; a 55 kD type I transmembrane glycoprotein; has been shown to play roles in lymphocyte differentiation; activation; and proliferation. Many resting memory T cells constitutively express IL2Ralpha. It functions as the receptor for HTLV-1; resulting in its expression on neoplastic cells in adult T cell lymphoma/leukemia. CD25 (sIL-2R) has been used to track disease progression. Some additional clinical applications include Chagas disease; a disease characterized by a decline of CD25 expression on immune cells; and Multiple sclerosis; in which treatments with mAbs target CD25. Anti-Human IL-2R alpha (CD25) (Basiliximab) utilizes the same variable regions from the therapeutic antibody Basiliximab making it ideal for research projects.
- Host:
- Human
- Immunogen:
- Human CD25
- Isotype:
- Human IgG1k
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- This R-phycoerythrin (R-PE) conjugate is stable when stored at 2-8[o]C. Do not freeze.
- Supplier:
- Abeomics
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:download_pdf.php
